Show simple item record

dc.contributor.advisorPeter Hutten_US
dc.contributor.authorLiu, Kassity Yefei
dc.date.accessioned2012-05-19T22:01:59Z
dc.date.issued2011
dc.identifier.citationKassity Yefei Liu, FDA and Social Media: The Impact of Social Media on Prescription Drug Advertising (September 2011).en_US
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:8789614
dc.description.abstractThe U.S. Food and Drug Administration (FDA) regulates the promotion of prescription drugs. With the emergence of Web 2.0 technology and social media, the FDA faces new regulatory challenges as pharmaceutical companies have started to use social media tools to market prescription drugs to consumers. This paper first explores the history of social media, its use by the FDA, and its growing use by the pharmaceutical industry. The paper then discusses some of the actions that the agency has taken to respond to the industry’s use of social media. Lastly, the paper takes a look at the FDA’s repeated delays in issuing social media guidance, and discusses some of the “social media guidance” that pharmaceutical companies have received from other individuals and groups.en_US
dash.licenseLAA
dc.subjecthuman drugs>>prescription drug promotion>>physician advertisingen_US
dc.subject.otherFood and Drug Lawen_US
dc.titleFDA and Social Media: The Impact of Social Media on Prescription Drug Advertisingen_US
dc.typePaper (for course/seminar/workshop)en_US
dash.depositing.authorLiu, Kassity Yefei
dc.date.available2012-05-19T22:01:59Z
dash.contributor.affiliatedLiu, Kassity Yefei


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record